A randomized, double-blind, placebo controlled study to evaluate the effect of cisplatin/epinephrine injectable gel (product MPI 5010) when administered intratumorally for achievement of treatment goals in recurrent or refractory squamous cell carcinoma of the head and neck

Trial Profile

A randomized, double-blind, placebo controlled study to evaluate the effect of cisplatin/epinephrine injectable gel (product MPI 5010) when administered intratumorally for achievement of treatment goals in recurrent or refractory squamous cell carcinoma of the head and neck

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 18 Dec 2013

At a glance

  • Drugs Cisplatin; Epinephrine
  • Indications Head and neck cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 20 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top